[Federal Register Volume 75, Number 132 (Monday, July 12, 2010)]
[Notices]
[Pages 39667-39668]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-16891]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Non-Exclusive or Partially Exclusive Licensing 
of a U.S. Patent Application

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Announcement is made of the availability for licensing of the 
invention set forth in U.S. Patent Application Serial No. 11/132,199, 
entitled ``Construction of Live Attenuated Shigella Vaccine Strains 
that Express CFA/I Antigens (CFAB and CFAE) and the B Subunit of Heat-
Labile Enterotoxin (LTB) From Enterotoxigenic E. Coli,'' filed May 19, 
2005. The United States Government, as represented by the Secretary of 
the Army, has rights to this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research and Technology Applications (ORTA), (301) 619-
6664, both at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: The invention relates to materials and 
methodologies for preparing multivalent vaccines, recombinant DNA 
expression

[[Page 39668]]

products and more particularly to vector constructs which effectively 
express the cfaB, cfaE and LTB proteins in Shigella spp. without 
affecting the ability of the Shigella strain to invade cells of the 
colonic epithelium following oral administration to humans.

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2010-16891 Filed 7-9-10; 8:45 am]
BILLING CODE 3710-08-P